Category: Debates & Comparisons
Fish oil has always been the default source of EPA and DHA. Algal oil, drawn from the same microalgae fish get their omega-3 from in the first place, is catching up fast. Here is the honest comparison on bioequivalence, evidence, contaminants, sustainability, taste and cost.
Category: Debates and Comparisons | Reading time: ~13 min | Level: Intermediate
For decades the omega-3 aisle only had one real option, and it smelled like it. Fish oil was the default, the thing your grandmother kept in the fridge, the capsule that occasionally repeated on you an hour after breakfast. Algal oil, drawn from cultivated microalgae rather than fish, used to be the niche alternative for vegans who wanted the same nutrient without the animal source, and it carried a quiet assumption that it was probably a slightly worse version of the real thing.
That assumption is now out of date, and the evidence is specific about why. Fish do not manufacture EPA and DHA themselves in any meaningful way. They get it by eating algae, or by eating something that ate algae, and it works its way up the marine food chain from there. Algal oil is not a substitute molecule standing in for the "real" omega-3, it is the same two compounds taken from their actual biological origin. The interesting question, once you know that, is not whether algal oil is a passable imitation. It is whether taking omega-3 from its source rather than from the middle of the food chain changes anything that matters to you: how well it is absorbed, what it costs, what else comes along with it, and what it does for your health once it is in your body.
Both are delivery systems for the same two long-chain omega-3 fatty acids, EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) [1]. Fish oil is extracted from oily fish such as salmon, sardines, anchovies and mackerel, which accumulate EPA and DHA through their diet. Algal oil is extracted directly from cultivated microalgae, grown in controlled tanks rather than harvested from the ocean, and it is the original source of the same fatty acids that fish oil ultimately comes from [8].
A third omega-3, ALA (alpha-linolenic acid), is a different, shorter-chain molecule found in flaxseed and walnuts, and the body converts it to EPA and DHA only weakly, so it is not a substitute for either fish or algal oil if you specifically want EPA and DHA levels to move [1]. This comparison is about the two sources that deliver EPA and DHA directly, not about plant ALA.
Because fish oil and algal oil deliver the same active compounds, the underlying evidence for what EPA and DHA do in the body applies to both sources equally. What differs between the two is bioavailability, purity profile and origin, covered in the next sections. Here is the honest state of the core evidence.
Triglyceride lowering is the strongest, most consistent claim. A Cochrane review of 86 trials and 162,796 participants found long-chain omega-3s reduced serum triglyceride levels by around 15 percent, with a clear dose response: each additional gram a day produced a further measurable drop, and the effect was larger in people who started with higher triglycerides [4]. This is the one place the evidence for omega-3 is genuinely solid, and it applies to a purified supplement dose, not to eating oily fish occasionally.
Cardiovascular benefit is real but more contested, and population matters more than the headline suggests. Several major trials point in different directions depending on who was studied and how much was given: primary prevention trials in generally healthy people have mostly found no significant reduction in combined major cardiovascular events, while trials in people with existing heart disease, high triglycerides or genuinely low dietary fish intake tend to show more benefit [1]. A large pooled analysis of 38 trials and 149,051 participants found omega-3 supplementation reduced cardiovascular mortality, non-fatal heart attacks and coronary events, and specifically found EPA-only supplementation outperformed combined EPA-plus-DHA on cardiovascular mortality [6]. The honest grade is moderate for cardiovascular risk in the right population, existing heart disease, high triglycerides, low baseline fish intake, and weak as a blanket claim for otherwise healthy people, which is why most cardiology guidance does not recommend routine omega-3 supplementation for people without elevated cardiovascular risk.
Two safety signals matter more than most marketing acknowledges, and both are covered in full under Safety below: a dose-dependent rise in atrial fibrillation risk at higher intakes, and a genuine, if modest, antiplatelet and bleeding effect at high doses. Neither signal depends on whether the EPA and DHA came from a fish or an algae source, because the compounds themselves are identical.
This is the question that used to have a genuinely uncertain answer, and it does not anymore. A 2025 randomised, double-blind, placebo-controlled trial measured plasma phospholipid DHA and EPA levels in 74 adults after 6 and 14 weeks of either microalgal or fish oil supplementation, and found the two statistically non-inferior to each other, with a geometric mean ratio for combined DHA and EPA of 112 percent, comfortably inside the accepted equivalence range [8]. An earlier bioequivalence trial, comparing algal oil capsules directly against DHA delivered from cooked salmon, found the two delivered DHA to blood plasma and red blood cells equally well [9].
The practical read is straightforward: well-formulated algal oil is not a lesser substitute for fish oil on the measure that actually matters, how much EPA and DHA ends up in your circulation. The one genuine variable to check is the product itself rather than the source category. Historically, algal oil supplements leaned heavily toward DHA because it was easier to produce at scale, so anyone specifically chasing the EPA-linked triglyceride and cardiovascular evidence should check a given algal product's EPA content rather than assuming it matches a fish oil capsule gram for gram.
| Feature | Fish oil | Algal oil | |---|---|---| | Source | Oily fish (salmon, sardines, anchovies, mackerel) | Cultivated microalgae, grown in controlled tanks | | Active compounds | EPA and DHA | EPA and DHA, same molecules | | Bioavailability | Well established baseline | Statistically comparable in recent randomised trials [8][9] | | Vegan or vegetarian suitable | No, animal derived | Yes | | Marine contaminant exposure | Possible, depending on sourcing and purification; reputable brands test and refine | Minimal; cultivated in closed systems, not the marine food chain [8] | | Sustainability | Depends on fishery; wild stocks face real pressure | Generally more sustainable, cultivated rather than harvested | | Typical taste and oxidation | Can develop a fishy taste or aftertaste as it oxidises | Commonly reported as milder tasting, generally more oxidatively stable | | EPA content | Usually well represented, often the primary compound | Varies more by product; historically DHA-dominant, EPA formulas now more available | | Cost per gram of EPA and DHA | Typically lower | Typically higher, reflecting production scale | | Safety signals (AF, bleeding) | Present at high intakes | Present at high intakes; identical, since the active compounds are the same |
Start with what you actually need the omega-3 for, then let that decide the dose, and only then worry about source.
If you are chasing the triglyceride or cardiovascular evidence specifically, the dose and the EPA content of the product matter far more than whether it came from fish or algae, since both deliver the same molecules at comparable bioavailability [8][9]. Check the label for actual EPA and DHA milligrams per serving, not just "fish oil 1000mg," since a large capsule of low-concentration oil can deliver a surprisingly small dose of the two compounds that matter.
If you do not eat fish, whether for ethical, religious or personal reasons, algal oil is not a compromise choice. The bioequivalence evidence means you are not trading away meaningful absorption to avoid an animal product [8][9]. If contaminant exposure or sustainability weighs on your decision independent of any nutritional difference, algal oil has a genuine, evidence-backed edge on both counts, since it never enters the marine food chain where mercury and other pollutants accumulate [8].
If cost or EPA concentration is your main constraint, fish oil remains the more accessible option, typically cheaper per gram of combined EPA and DHA and more reliably available at higher EPA doses. Reputable fish oil brands test for and remove contaminants as part of standard refining, so contaminant exposure from a purified supplement is a smaller concern than from eating whole fish, though it is not zero the way algal oil's exposure is.
This is not a contest with one universal winner, because the two answer slightly different questions well.
Choose algal oil if you are vegan or vegetarian, since it is the only source of direct EPA and DHA that does not involve an animal product, and the bioequivalence evidence means you are not settling for a lesser option to get there. Choose algal oil too if avoiding marine contaminant exposure or supporting a more sustainable supply chain matters to you independent of the nutrition, since both are genuine, defensible advantages of cultivated algae over wild or farmed fish. Choose fish oil if you want the lowest cost per gram of EPA and DHA, or if you specifically need a higher EPA dose and want the widest, most affordable selection of concentrated EPA products, since fish oil formulations still dominate that end of the market. For everyone else asking a more general "should I take omega-3 at all" question, the source matters less than the dose and the reason you are taking it in the first place, because the underlying evidence, and the underlying safety signals at high intakes, belong to EPA and DHA themselves, not to which animal or organism they travelled through on the way to your capsule.
Our own Omega-3 product delivers 180mg EPA and 120mg DHA per serving, 300mg combined, which sits well below the 1 to 1.5g a day range where the atrial fibrillation and bleeding signals discussed below start to appear [1][5][6]. That is a genuinely low, everyday maintenance dose, not a therapeutic dose aimed at the triglyceride or cardiovascular trial evidence, and we would rather say that plainly than let the word omega-3 imply a bigger effect than a 300mg serving is positioned to deliver. If your goal is the higher-dose triglyceride or cardiovascular story specifically, that is a conversation about dose and monitoring with your GP, not a shelf decision.
If you are working out which source and which dose actually fits your goal, our Remedy Library sets out products by what they are actually studied for, and our supplement label forensics guide is a useful companion for reading past "1000mg fish oil" on a bottle to what the EPA and DHA content underneath it actually is.
Both fish oil and algal oil carry the same safety profile at the same dose, because the active compounds are identical. Two signals matter more than most marketing acknowledges.
Atrial fibrillation risk rises with dose. The NIH's own synthesis states plainly that two large clinical trials found taking 4g a day of omega-3 supplements for several years slightly increased atrial fibrillation risk in people with cardiovascular disease or at high cardiovascular risk [1]. A dedicated meta-analysis of 7 trials and 81,210 patients found marine omega-3 associated with a 25 percent relative increase in atrial fibrillation risk, and the risk was clearly dose graded, greater above 1g a day than at or below it [5]. The newest and largest pooling, a 2025 preprint of 34 trials and 114,326 people not yet peer reviewed, narrows this further: only people at high cardiovascular risk taking more than 1.5g a day showed a statistically significant increase, with an absolute risk difference of under 1 percent, while lower doses and lower-risk groups showed no significant increase [7]. Treat this as a real, dose-dependent signal concentrated in higher-risk people taking higher doses, not a reason to avoid a low, everyday-maintenance dose.
Bleeding risk is real at high doses and modest at typical ones. Doses of 2 to 15g a day EPA and DHA can increase bleeding time by reducing platelet aggregation, and a large pooled analysis found EPA-only supplementation raised total bleeding risk by around 49 percent relative to control [1][6]. The counterweight is also documented: up to 5g a day EPA plus DHA is generally considered safe, most research finds 3 to 6g a day fish oil does not significantly affect warfarin's anticoagulant effect, and clinically significant bleeding has not been established at typical supplement doses [1]. The sensible position is caution and periodic monitoring if you combine omega-3 with an anticoagulant or antiplatelet medicine such as warfarin, a DOAC, aspirin or clopidogrel, and a pause before planned surgery, regardless of whether your omega-3 comes from fish or algae.
Liver safety is clean for omega-3 generally. LiverTox gives it a likelihood score of E, its lowest category, stating omega-3 fatty acids "have not been implicated in causing serum enzyme elevations or clinically apparent liver injury" [3]. Pregnancy and breastfeeding are not a concern either; DHA is actively recommended during pregnancy, with several bodies suggesting an extra 100 to 200mg a day, and the main pregnancy-related caution around omega-3 is about mercury in whole fish, not about a purified fish or algal oil supplement [1].
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
1. NIH Office of Dietary Supplements (2026). Omega-3 Fatty Acids, Fact Sheet for Health Professionals. ods.od.nih.gov, retrieved via Internet Archive snapshot dated 2026-07-10. Forms, dose context, triglyceride and cardiovascular synthesis, atrial fibrillation and bleeding statements, pregnancy and mercury guidance. 2. National Center for Complementary and Integrative Health (2026). Omega-3 Supplements: In Depth. nccih.nih.gov/health/omega3-supplements-in-depth, retrieved 2026-07-12. 3. NIH LiverTox (2026). Omega-3 Fatty Acids. NBK548910, retrieved 2026-07-12. Hepatotoxicity likelihood score E. 4. Abdelhamid AS, et al. (2020). Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease, 86 trials, 162,796 participants. Cochrane Database of Systematic Reviews. PMID 32114706. 5. Gencer B, et al. (2021). Effect of long-term marine omega-3 fatty acids supplementation on the risk of atrial fibrillation, 7 trials, 81,210 patients. Circulation. PMID 34612056. 6. Khan SU, et al. (2021). Effect of omega-3 fatty acids on cardiovascular outcomes, 38 trials, 149,051 participants. EClinicalMedicine. PMID 34505026. 7. Abuknesha NR, O'Keefe JH, Harris WS, et al. (2025). Effects of omega-3 fatty acid treatment on risk for atrial fibrillation, an updated meta-analysis of 34 trials including 114,326 individuals. medRxiv, preprint, not yet peer reviewed. PMID 41445624. 8. Bailey E, Wojcik J, Rahn M, Roos F, Spooren A, Koshibu K (2025). Comparative bioavailability of DHA and EPA from microalgal and fish oil in adults, randomised double-blind placebo-controlled trial, n=74. International Journal of Molecular Sciences. PMID 41096614. 9. Arterburn LM, Oken HA, Hoffman JP, et al. (2007). Bioequivalence of docosahexaenoic acid from different algal oils in capsules and in a DHA-fortified food. Lipids. PMID 17713804. 10. PlantRx live Shopify store, plantrxapp.myshopify.com. Omega-3 EPA 180mg + DHA 120mg product record, retrieved 2026-07-12.
On the measure that matters most, how much EPA and DHA actually reaches your bloodstream, yes. A 2025 randomised trial comparing microalgal and fish oil supplements over 14 weeks found statistically non-inferior plasma bioavailability between the two, and an earlier bioequivalence study found algal oil capsules delivered DHA to plasma and red blood cells as effectively as cooked salmon. The two sources are not identical products, but the core nutritional claim, that algal oil is a reliable, bioavailable source of DHA and EPA, holds up.
Fish do not make EPA and DHA themselves in meaningful amounts. They accumulate it by eating algae directly, or by eating smaller fish that ate algae, working up the marine food chain. Algal oil supplements simply take that omega-3 from its original source, cultivated microalgae, rather than routing it through a fish first.
It depends on the product. Most algal oil supplements historically leaned DHA-heavy, since that was the easier compound to produce at scale from algae, but EPA-containing and EPA-plus-DHA algal products are now widely available. If you specifically need a higher EPA dose, most commonly for the cardiovascular and triglyceride evidence, check the label rather than assuming, since algal EPA content varies more between brands than fish oil EPA content does.
Algal oil is cultivated in controlled tanks rather than harvested from the ocean, so it does not pass through the marine food chain where mercury and other pollutants accumulate. This is one of algal oil's clearest practical advantages for anyone concerned about contaminant exposure, though reputable fish oil brands also test and purify their products, and mercury itself is mainly a concern with eating whole fish rather than a purified fish oil supplement.
Algal oil is generally the more sustainable choice, because it is cultivated rather than harvested from wild or farmed fish stocks, and does not depend on the marine supply chain that supports conventional fish oil production. If sustainability is a deciding factor for you, that is a genuine, evidence-backed reason to choose algal oil, independent of any nutritional difference between the two.
No, fish oil is an animal product regardless of how the fish were farmed or caught, so it is not suitable for vegetarians or vegans. Algal oil is the direct plant-based, or more precisely microalgae-based, alternative that delivers the same EPA and DHA compounds without an animal source.
Fish oil is typically the cheaper option per gram of EPA and DHA delivered, reflecting a more established, larger-scale production process. Algal oil production is more specialised and tends to cost more for an equivalent dose, though prices have been narrowing as demand and manufacturing scale grow.
Not on the nutritional evidence. Randomised trials directly comparing plasma bioavailability of DHA and EPA from microalgal and fish oil supplements have found them statistically comparable, and an earlier bioequivalence study found algal DHA capsules performed as well as cooked salmon at raising DHA levels. The honest caveat is checking the specific product's EPA content, since some algal formulas lean heavily toward DHA, so match the label to whichever compound your goal depends on more.
No. The antiplatelet effect and the atrial fibrillation signal seen at high intakes are properties of EPA and DHA themselves, not of whether they came from fish or algae. If you are on an anticoagulant or antiplatelet medicine, or take more than roughly 1 to 1.5g a day combined EPA and DHA from any source, that conversation with your prescriber about monitoring is the same regardless of which oil you choose.
Many people report that algal oil has a milder, more neutral taste and is less prone to the fishy aftertaste or burps some people get from fish oil, and it is generally considered less prone to rapid oxidation. This is a commonly reported formulation difference rather than a rigorously quantified clinical finding, so individual experience varies, and both fresh, well-stored oils of either type should not smell or taste strongly rancid.